Fill / Finish Lines
Novocol Pharma’s fill/finish infrastructure is engineered for precision, sterility, and scalability across cartridge and prefilled-syringe formats. Isolator and RABS aseptic filling, RTU flexibility, and automated decontamination systems support fast setup, consistent aseptic performance, and high-volume commercial throughput. From early clinical batches to sustained supply, Novocol Pharma provides reliable execution backed by decades of aseptic filling expertise.
Aseptic Filling Infrastructure Designed for Reliability and Throughput
The Cambridge facility houses a suite of specialized lines that support cartridge, syringe, and select vial presentations. Together, they create a manufacturing ecosystem with the flexibility to manage development-scale lots as well as high-speed commercial demand.
Cartridge Lines (Aseptic + Terminal Sterilization Capability)
Novocol Pharma operates multiple cartridge-dedicated lines built around Syntagon fillers and long-established mechanical expertise.
These include:
- Unit 4 cartridge line operating continuously with manufacturing precision refined over years in operation.
- Unit 5 aseptic line introduced during the Vista expansion, delivering roughly 2x the throughput of Unit 4 and optimized for reduced operator intervention.
- Both systems support 1 mL to 3 mL cartridge formats, with capability to adapt to specialty volumes as required.
- Processes include washing, siliconization, depyrogenation, aseptic filling, and mechanical closure control — areas where Novocol Pharma’s cartridge heritage provides strong technical expertise.
Unit 6 RTU Isolator Line (Syringes, Cartridges, and Vials)
A flexible Groninger line with SKAN isolator supports RTU components across multiple formats, enabling secure processing with minimal glove port intervention.
Capabilities include:
- RTU syringe filling for common tub formats covering 0.5 mL to 2.25 mL presentations
- RTU cartridge handling for 1 mL and 3 mL configurations
- Vial feasibility across 2R to 20R, suitable for clinical batches or specialty use
- Automated H2O2 decontamination cycles
- Rapid-transfer ports (RTPs) for contained introduction of stoppers, plungers, and tools
- Integrated check-weighing and closure system inspection
This line provides a versatile option for early-phase programs or commercial products requiring RTU processing and enhanced sterility assurance.
Filling Capabilities by Format
Cartridges remain Novocol Pharma’s strongest specialization. Filling volumes as low a 0.5 mL in 1–3 mL cartridges are supported, with the ability to accommodate glass or polymer formats depending on client needs. Strong insight into silicone distribution, plunger break loose and glide force, plunger insertion depth, needle interface, and mechanical tolerances helps protect downstream device performance for manual, pen, or autoinjector delivery systems.
The RTU line supports sterile syringe presentations commonly used for biologics, peptides, and small molecules developed for acute or chronic therapies. Viscosity management, slow-speed or low-shear fills, and line settings optimized for consistent accuracy support a broad range of formulations.
Novocol Pharma’s isolator equipment allows for vial processing in 2R to 20 R, with feasibility up to 50R with custom tooling, supporting clinical supplies or niche product manufacturing.
Line 5 Expansion: 
High-Speed Cartridge Capacity Coming 2026
Novocol Pharma’s planned Line 5 investment expands cartridge filling capacity to meet rising demand for chronic therapeutic injectables such as peptide-based therapies, as well as acute small molecule therapies. Targeted for 2026, this new line introduces:
- High-speed aseptic filling purpose-built for commercial-scale cartridge programs
- Engineering improvements that reduce changeover complexity
- Compatibility with 1–3 mL cartridges, with potential extension to specialty configurations
- Integrated inspection, automated weight checks, and advanced closure verification
Process Controls and Validation Framework
Strong process discipline underpins Novocol Pharma’s fill-finish reliability. All lines operate within a validated ecosystem that includes rigorous aseptic behaviors, automated checks, and sustained Quality oversight.
Key Elements of Novocol Pharma’s Process Control System
- Automated H2O2 decontamination cycles for isolator sterility
- Environmental monitoring across ISO-classified cleanrooms
- Weight checks, fill-accuracy verification, and reject management
- Semi-automated and automated visual inspection
- Integrated CCI verification for cartridges, syringes, and vials
- Documented line-clearance and batch-record workflows
Validation Performance
Media fill programs have successfully completed more than 500,000 units with zero growth positives, reflecting both operator proficiency and strong aseptic practices.
Advanced Handling for Specialized Modalities
- Administrative and engineering controls for high-potency compound handling for cartridges and RTU
- CIP/SIP-equipped compounding infrastructure for sterile transfers and closed processing functions
These features provide a robust foundation for complex sterile programs requiring high containment or unique process controls.